This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
A new preprint design is coming!
We have improved readability, clarity, accessibility, and opportunities for engagement.
Research
Lin Kang
Shenzhen People's Hospital
Corresponding Author
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background: Ovarian cancer is the most lethal gynaecological malignancy, resulting in approximately 14,000 deaths annually in the United States. Transcriptome data are emerging as an effective tool possibly leading to clinical applications for various cancers.
Methods: We collected eight serous ovarian carcinomas (SOCs) and eight normal ovary samples, and generated a whole transcriptome profile of human ovarian cancer using microarrays, including mRNAs, lncRNAs, and circRNAs. We constructed a competing endogenous RNA (ceRNA) network involving these three types of RNAs and identified immune-related circRNAs from the network. Moreover, we proposed a gene-pair filtering method to identify significant expression reversals from integrated multi-cohorts, which mitigates the technical variation and improves the statistical power.
Results: Three pairs of mRNAs (BIRC5:PRKCQ, PTK2B:OGN, and S100A14:NR2F1) were identified as promising biomarkers and were fused as an indicator (SOC index) for diagnostic prediction. Validation in three independent cohorts demonstrated that the SOC index carries a very high predictive capacity (average ROC, 0.99; sensitivity, 0.98; specificity, 1.00). Additionally, the SOC index exhibited its prognostic potential to discriminate SOC patients between early and late stage disease.
Conclusions: Our findings elucidate the repertoire of RNA expressions in SOC and identified three gene pairs for the primary screening of SOC. Further biological experiments of the three gene pairs are warranted in order to investigate the underlying function mechanisms involved in ovarian cancer development.
Keywords
Serous ovarian cancer, Transcriptome, ceRNA, Biomarker, Diagnosis, Prognosis
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
The full text of this article is available to read as a PDF.
This is a list of supplementary files associated with this preprint. Click to download.
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 07 May, 2021
No community comments so far
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Learn more about our company.
A new preprint design is coming!
We have improved readability, clarity, accessibility, and opportunities for engagement.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Research
Lin Kang
Shenzhen People's Hospital
Corresponding Author
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 07 May, 2021
No community comments so far
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background: Ovarian cancer is the most lethal gynaecological malignancy, resulting in approximately 14,000 deaths annually in the United States. Transcriptome data are emerging as an effective tool possibly leading to clinical applications for various cancers.
Methods: We collected eight serous ovarian carcinomas (SOCs) and eight normal ovary samples, and generated a whole transcriptome profile of human ovarian cancer using microarrays, including mRNAs, lncRNAs, and circRNAs. We constructed a competing endogenous RNA (ceRNA) network involving these three types of RNAs and identified immune-related circRNAs from the network. Moreover, we proposed a gene-pair filtering method to identify significant expression reversals from integrated multi-cohorts, which mitigates the technical variation and improves the statistical power.
Results: Three pairs of mRNAs (BIRC5:PRKCQ, PTK2B:OGN, and S100A14:NR2F1) were identified as promising biomarkers and were fused as an indicator (SOC index) for diagnostic prediction. Validation in three independent cohorts demonstrated that the SOC index carries a very high predictive capacity (average ROC, 0.99; sensitivity, 0.98; specificity, 1.00). Additionally, the SOC index exhibited its prognostic potential to discriminate SOC patients between early and late stage disease.
Conclusions: Our findings elucidate the repertoire of RNA expressions in SOC and identified three gene pairs for the primary screening of SOC. Further biological experiments of the three gene pairs are warranted in order to investigate the underlying function mechanisms involved in ovarian cancer development.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
The full text of this article is available to read as a PDF.
This is a list of supplementary files associated with this preprint. Click to download.
Loading...